Editorial Policies

AUTHORSHIP CRITERIA

All the authors named as such in the manuscript must have agreed to authorship, read and approved the manuscript, and given consent for submission and subsequent publication of the manuscript.

Each author, and any co-authors, must also meet the following criteria:

1. All must have made a significant contribution to the design of the study, the collection of data, or the analysis and interpretation of data and
2. All must, either by writing or by helping to edit the manuscript, have contributed to the design of its intellectual content to a significant degree.

Each author must also be able to take responsibility for part of the article's content and be able to identify which co-authors are responsible for the remaining parts.

AUTHOR SELF-ARCHIVING

Article authors have the right to self-archive the submitted ("preprint") version of the manuscript and the postprint version without any embargo period.

Submitted manuscripts and published versions of articles can, for example, be archived on:

• The author's personal website
• The author's employer’s website and/or institutional repository or archive
• Non-profit preprint servers or subject-based archives

PREPRINT POLICY

The Journal's editors allow authors to upload earlier drafts of manuscripts/articles on the condition that authors agree to the following:

• Authors retain all rights to any previously published version and are permitted to submit their updated manuscript to the Journal.
• Authors accept that the Journal's editors cannot guarantee full anonymity in the review process, even if the author anonymizes the manuscript when earlier versions of the manuscript are made available.

If the manuscript is published in the Journal, the author is expected to cross-link, with DOI link, the different versions of the manuscript/article.

ORCID

The Journal's editors strongly recommend that authors submitting manuscripts register an "Open Researcher and Contributor Identifier" or ORCiD.

This registration provides a unique and stable digital author identity that ensures that the article is attributed to the correct person and improves the searchability of all the author's publications. This helps to ensure that the author receives recognition for their work. As a person's ORCiD remains the same as long as the account exists, any name changes, change of employment, department affiliation or research field do not affect the searchability of previous publications. This facilitates correspondence between research colleagues.

The Journal's editors encourage all authors to include ORCiD along with other author information when the manuscript is registered in the system. If the article is accepted, this will be published with the article. 

OPEN DATA

As research funders' and universities' demands for open research data become increasingly common, some authors may be obliged to make their collected empirical material open and available to everyone.

In cases where this applies to the Journal's authors, the Journal's editors encourage that the material be made available according to the FAIR principles (Findable, Accessible, Interoperable, Reusable).

The material thus made available must be linked to within the submitted manuscript under a special heading. Research data should then be made public when the article is published. Empirical material obtained from other researchers must be referenced in the same way as other scientific sources. For further questions about guidelines for handling open data and guidelines about how data should be handled and published, please contact your university.

ARCHIVING POLICY

The Journal's current and future content, beginning when the Journal joining Publicera, is made available via Publicera and stored long-term on a secure and central servers at the National Library of Sweden. All old material published before JEVTM joined Publicera, is stored at servers at jevtm.com, Örebro University Hospital and at Lund University. In the event that the Journal ceases operations, the Journal's content on Publicera will remain archived at the National Library of Sweden.

CORRECTION AND RETRACTION POLICIES

The conditions of publication with persistent identifiers such as DOIs include that the object published is final and not changed without readers being clearly informed of such changes.

Articles published in the Journal can therefore not be changed without a) an erratum or b) a change notice being published and linked to the original article.

If a factual error in an article is discovered, this should be reported to the Editor-in-chief, who decides on possible actions and possible corrections.

The Journal encourages post-publication discussion through Letters to the Editor or on an externally moderated website for review and post-publication discussion of research, such as PubPeer.

In order to maintain the highest scientific standards, the Journal follows strict quality standards:

Upon request, authors should be prepared to send relevant documentation or data in order to verify the validity of the results presented. This could be in the form of raw data, samples, records, etc. Sensitive information in the form of confidential or proprietary data is excluded.

If there is suspicion of misbehavior or alleged fraud, the Journal and/or Publisher will carry out an investigation following COPE's guidelines. If, after investigation, there are valid concerns, the author(s) concerned will be contacted via their given email address and given an opportunity to address the issue. Depending on the situation, this may result in the Journal’s and/or Publisher’s implementation of the following measures, including, but not limited to:

• If the manuscript is still under consideration, it may be rejected and returned to the author.
• If the article has already been published online, depending on the nature and severity of the infraction, one or more of the following measures may be taken:
  – an erratum/correction may be placed with the article
  – an expression of concern may be placed with the article
  – in severe cases, the article may be retracted

The reason will be given in the published erratum/correction, expression of concern, or retraction note. Please note that retraction means that the article is maintained on the platform, watermarked “retracted”, and the explanation for the retraction is provided in a note linked to the watermarked article.

Authors have an obligation to correct mistakes once they discover a significant error or inaccuracy in their published article. The author(s) is/are requested to contact the Journal and explain in what sense the error is impacting the article. A decision on how to correct the literature will depend on the nature of the error. This may be a correction or retraction. The retraction note should provide transparency as to which parts of the article are impacted by the error.

REPORTING GUIDELINES

Authors are encouraged to follow CONSORT guidelines when presenting randomized controlled trials and provide the CONSORT checklist at manuscript submission, with an accompanying flow diagram illustrating the progress of patients through the trial - including recruitment, enrolment, randomization, withdrawal, completion and a description of the randomization procedure. When reporting on non-randomized trials, the TREND guidelines and the TREND checklist should be applied.

The intervention in both randomized and non-randomized trials should be described according to the requirements of the TIDieR checklist and guide. Submissions must also include the study protocol as supporting information, which will be published with the manuscript if accepted.

Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file.

For Case Reports, authors should follow the CARE Reporting Guidelines and a completed CARE checklist should be uploaded during submission. This will increase the accuracy, transparency, and usefulness of case reports.

All checklists and illustrations mentioned above, which are relevant for your study, should be uploaded with your submission as supplementary files.

We also recommend authors to look for additional Reporting Guidelines available at https://www.equator-network.org/ when required.

SPONSORSHIP

All financial or in-kind support provided by a sponsor, company, funder or other part, must be clearly and fully disclosed by the authors. This information should be included on the Title page under the heading Funding Declaration.

The role of sponsors, if any, should be declared in relation to the study design, collection, analysis and interpretation of data, writing of the report and decision to submit the article for publication. If funding sources had no such involvement this should be stated in your submission.

ADVERTISING POLICIES

Advertisements on the JEVTM website or any of the EVTM platforms do not imply endorsements by the Journal, its editors, owners, or affiliated societies. Advertising never influences editorial decisions or published content.

Allowed advertising includes professionally relevant material such as medical devices, educational tools, conferences, courses, and academic job postings.

Not permitted advertisement includes pharmaceutical promotions, products with unverified clinical claims, political or non–professionally relevant commercial content, or any advertisement that conflicts with scientific or ethical standards.

All advertising requests are reviewed by the Journal’s administrative team in consultation with the Editor-in-Chief. Approval is based on relevance, accuracy, ethical compliance, and absence of conflicts of interest. The Journal may decline or withdraw advertisements at its discretion.